患者管理ソリューション市場：コンポーネント（ソフトウェア、サービス）、デリバリー（オンプレミス、クラウド）、治療領域（CVD、糖尿病、肥満、フィットネス）、機能（電子処方、バーチャルケア）、エンドユーザー（プロバイダー、ペイヤー、患者）別 - 2027年までの世界市場予測

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) - Global Forecast to 2027

患者エンゲージメントソリューション市場は、2022年の173億米ドルから2027年には279億米ドルに達すると予測され、予測期間中のCAGRは10.0%となります。この市場の成長は、患者中心のケアを推進し、ケアジャーニー... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年5月6日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	205	180	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

患者エンゲージメントソリューション市場は、2022年の173億米ドルから2027年には279億米ドルに達すると予測され、予測期間中のCAGRは10.0%となります。この市場の成長は、患者中心のケアを推進し、ケアジャーニー全体で患者を巻き込むための政府規制の導入や変更、患者エンゲージメントソリューションに対する高い需要、M-ヘルスアプリの利用拡大が要因となっています。
しかし、患者エンゲージメントソリューションの相互運用性の問題や、医療業界における熟練したIT専門家の不足が、予測期間中の同市場の成長を抑制するものと思われます。

"サービス分野は予測期間中に最も高い成長率を示すと予想される"
患者エンゲージメントソリューション市場は、コンポーネント単位で、ソフトウェア、ハードウェア、サービスに区分されます。2021年の世界の患者エンゲージメントソリューション市場では、ソフトウェア部門が最大のシェアを占めています。ソフトウェア市場はさらに、スタンドアロンソリューションと統合ソリューションに区分されます。2021年には、統合ソリューションセグメントがこの市場でより大きなシェアを占めており、また予測期間中に最も高いCAGRで成長すると予測されています。
しかし、サービス分野は予測期間中に最も高いCAGRで成長すると予想される。サービス分野の高い成長は、展開されたソリューションの適用にサービスが不可欠であることに起因しています。

"オンプレミスソリューションセグメントは、2022年に患者エンゲージメントソリューション市場で最大のシェアを占めると推定される"
デリバリーモードに基づき、患者エンゲージメントソリューション市場は、オンプレミス型とクラウド型に区分されます。2021年、世界の患者エンゲージメントソリューション市場では、オンプレミスソリューションセグメントが最大のシェアを占めています。しかし、クラウドベースのソリューションセグメントは、予測期間中に最も高いCAGRを記録すると予想されます。クラウドベースのソリューションが提供する柔軟性、拡張性、手頃な価格が、患者エンゲージメントソリューション市場における成長を支えている。

"患者エンゲージメントソリューションの世界市場において、アプリケーションの健康管理分野が最大のシェアを占める"

患者エンゲージメントソリューション市場は、アプリケーションに基づき、健康管理、在宅健康管理、社会・行動管理、財務健康管理に区分されます。2021年の世界の患者エンゲージメントソリューション市場では、健康管理アプリケーションのセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、重篤な疾患によって引き起こされる健康状態に対する患者の意識の高まりと、自身の健康維持に積極的に参加しようとする意欲に起因するものと考えられます。

"治療領域のうち慢性疾患が世界の患者エンゲージメントソリューション市場で最大のシェアを占める"

患者エンゲージメントソリューション市場は、治療領域に基づいて、慢性疾患、女性の健康、フィットネス、その他の治療領域に区分されます。2021年の患者エンゲージメントソリューションの世界市場では、慢性疾患分野が最大のシェアを占めています。このセグメントの大きなシェアは、さまざまな慢性疾患の増加と、医療費を削減しながらこれらの状態を管理する必要性に起因するものと考えられます。

"電子処方機能は予測期間中に最も高いCAGRで成長すると予想される"

患者エンゲージメントソリューション市場は、機能別に、E-prescribing、バーチャルコンサルテーション、患者/顧客スケジューリング、文書管理に区分されます。2021年の世界の患者エンゲージメントソリューション市場では、患者/顧客スケジューリングセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、予約の適切なスケジューリングによる生産性の向上と効率的なケアに起因していると考えられます。電子処方箋セグメントは、予測期間中に最も高いCAGRで成長すると予想される

"患者エンゲージメントソリューションの世界市場において、プロバイダーセグメントが最大のシェアを占める"

エンドユーザーに基づいて、患者エンゲージメントソリューション市場は、プロバイダー、ペイヤー、患者、その他のエンドユーザーに区分されます。2021年の世界の患者エンゲージメントソリューション市場では、プロバイダーセグメントが最大のシェアを占めています。医療費上昇の抑制、価値に基づくケアの提供、財務的成果の改善を目的とした患者エンゲージメントソリューションの高い導入が、このセグメントの成長を支えている要因です。また、患者エンゲージメントソリューションは、プロバイダーが患者の体験を改善し、健康情報への便利なアクセスに対する需要の高まりに対応し、患者が自分のケアを自己管理するためのより良いサービスを提供するのに役立ちます。

"2022年、患者エンゲージメントソリューション市場を支配するのは北米"
2021年の世界の患者エンゲージメントソリューション市場では、北米が最大のシェアを占めています。同地域における政府の取り組みや規制の変化、医療費削減の必要性、慢性疾患の増加、同地域で活動する主要な市場関係者が、北米の患者エンゲージメントソリューション市場の成長を促す主な要因となっています。
アジア太平洋地域は、HCITソリューションの採用が進んでいることと、慢性疾患の有病率が上昇していることから、予測期間中に最も高いCAGRを記録すると予測されています。

供給側一次インタビューの内訳、企業タイプ別、呼称別、地域別。
- 企業タイプ別企業タイプ別：Tier 1 (41%)、Tier 2 (31%)、Tier 3 (28%)
- 役職別Cレベル(44%)、ディレクターレベル(35%)、その他(21%)
- 地域別北米 (46%)、欧州 (26%)、アジア太平洋 (18%)、RoW (10%)

本市場における主なプレイヤーは、IBM（米国）、McKesson Corporation（米国）、Allscripts（米国）、Cerner Corporation（米国）、Epic Systems Corporation（米国）、Orion Health（ニュージーランド）、GetWellNetwork（米国）、athonahealth（米国）、Onview Healthcare（アイルランド）、MEDITECH（米国）、IQVIA（米国）、Get Real Health（米国）、などです。Cognizant（米国）、Symphony Care（米国）、Harris Healthcare（米国）、Kareo（米国）、CureMD Healthcare（米国）、eClinicalWorks（米国）、Lincor Solutions（米国）、AdvancedMD（米国）、WellStack（米国）、IQVIA（米国）、Vivify Health（米国）、Medhost（米国）、Validic（米国）MEDISYSINC（米国）およびPatient point LLC（米国）である。これらのプレイヤーは、患者エンゲージメントソリューション市場における製品提供を拡大するために、新製品の発売やパートナーシップにますます力を注いでいます。

調査対象範囲
- 本レポートでは、患者エンゲージメントソリューション市場をコンポーネント、デリバリーモード、治療分野、アプリケーション、機能、エンドユーザー、地域に基づいて調査し
- 市場の成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会および課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- レポートでは、ミクロ市場の成長動向、展望、リモート患者モニタリング市場全体への貢献度に関して調査しています。
- 主要5地域に関する市場セグメントの売上高を予測しています。

レポート購入の主なメリット

本レポートは、市場全体とサブセグメントに関する収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者を支援します。本レポートは、利害関係者が競争環境を理解し、より良いビジネスの位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、ステークホルダーが患者関与ソリューション市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。

ページTOPに戻る

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 28
1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.5.1 SCOPE-RELATED LIMITATIONS 30
1.5.2 METHODOLOGY-RELATED LIMITATIONS 30
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY RESEARCH 35
2.2 PRIMARY SOURCES 35
2.2.1 KEY INDUSTRY INSIGHTS 36
2.2.2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.3 MARKET SIZE ESTIMATION METHODOLOGY 37
FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.4 MARKET ESTIMATION 38
2.4.1 RESEARCH METHODOLOGY: MARKET ESTIMATION 39
2.4.2 APPROACH: END USER-BASED MARKET ESTIMATION 39
FIGURE 3 RESEARCH METHODOLOGY: MARKET ESTIMATION 39
2.4.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION 40
2.4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH 40
2.4.5 GROWTH FORECAST 40
FIGURE 4 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE LABORATORY INFORMATICS MARKET (2022–2027) 41
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
2.5 MARKET DATA ESTIMATION AND TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.6 ASSUMPTIONS FOR THE STUDY 43
2.7 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET 44
2.8 LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2022 VS. 2027 (USD MILLION) 45
FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2022 VS. 2027 (USD MILLION) 46
FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 47
FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2022 VS. 2027 (USD MILLION) 47
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2022 VS. 2027 (USD MILLION) 48
FIGURE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 49
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF
THE PATIENT ENGAGEMENT SOLUTIONS MARKET 50
4 PREMIUM INSIGHTS 51
4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW 51
FIGURE 14 RISING GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC
CARE DRIVE THE MARKET GROWTH 51
4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 52
FIGURE 15 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2021 52
4.3 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2021) 53
FIGURE 16 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021 53
4.4 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET 54
FIGURE 17 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care 56
5.2.1.2 Increasing adoption of patient engagement solutions 57
5.2.1.3 Rising number of collaborations and partnerships between stakeholders 57
TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022 57
5.2.1.4 Increasing utilization of mobile health apps 58
5.2.2 RESTRAINTS 58
5.2.2.1 Large investment requirements for healthcare infrastructure 58
5.2.2.2 Protection of patient information 59
5.2.2.3 Inadequate interoperability across healthcare providers 59
5.2.2.4 Shortage of skilled IT professionals in the healthcare industry 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Growth opportunities in emerging markets 60
5.2.3.2 Wearable health technology 61
5.2.3.3 Cloud-computing solutions 61
5.2.4 CHALLENGES 61
5.2.4.1 High deployments costs of healthcare IT systems 61
5.2.4.2 Low levels of healthcare literacy 62
5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET 62
5.4 CASE STUDIES 63
5.4.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE 63
5.4.1.1 Case 1: Need to reduce patient hospital stays 63
5.4.2 IMPROVE OUTPATIENT COMMUNICATION 63
5.4.2.1 Case 2: Rising need to curb miscommunication with discharged patients 63
5.4.3 PATIENT ENGAGEMENT STRATEGY 63
5.4.3.1 Case 3: Post-discharge care 63
5.5 ECOSYSTEM ANALYSIS 64
FIGURE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 64
5.6 TECHNOLOGY ANALYSIS 65
TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 65
5.7 REGULATORY ANALYSIS 66
5.7.1 HEALTH INSURANCE PORTABILITY AND
ACCOUNTABILITY ACT OF 1996 (HIPAA) 66
5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH) 66
5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017 66
5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015 66
5.7.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA 66
5.7.6 AFFORDABLE CARE ACT, 2010 66
5.8 PRICING ANALYSIS 67
5.9 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 4 PATIENT ENGAGEMENT SOLUTION MARKET:
PORTER’S FIVE FORCES ANALYSIS 67
5.10 INDUSTRY TRENDS 68
5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS 68
5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 68
5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE 69
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 70
6.1 INTRODUCTION 71
TABLE 5 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 71
6.2 HARDWARE 71
6.2.1 HARDWARE SOLUTIONS ARE AN INTERACTIVE EXPERIENCE
FOR PATIENTS & FAMILIES 71
TABLE 6 HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 72
6.3 SOFTWARE 72
TABLE 7 SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 72
TABLE 8 SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
6.3.1 STANDALONE SOFTWARE 73
6.3.1.1 Standalone software refers to the traditional
software installed in client systems 73
TABLE 9 STANDALONE SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 73
6.3.2 INTEGRATED SOFTWARE 74
6.3.2.1 Reduction in time spent on data management is driving the growth of this segment 74
TABLE 10 INTEGRATED SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 74
6.4 SERVICES 74
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO WITNESS
THE HIGHEST GROWTH IN THE FORECAST PERIOD 74
TABLE 11 SERVICES MARKET, BY REGION, 2020–2027(USD MILLION) 75
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 76
7.1 INTRODUCTION 77
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2020–2027(USD MILLION) 77
7.2 ON-PREMISE MODE 77
7.2.1 PATIENT DATA SAFETY AND COST BENEFITS OF
ON-PREMISE DELIVERY MODES TO DRIVE THE MARKET GROWTH 77
TABLE 13 ON-PREMISE MODE MARKET, BY REGION, 2020–2027(USD MILLION) 78
7.3 CLOUD-BASED MODE 78
7.3.1 REGULATORY REQUIREMENTS HAVE DRIVEN HEALTHCARE PROVIDERS
TO ADOPT CLOUD-BASED SOLUTIONS 78
TABLE 14 CLOUD-BASED MODE MARKET, BY REGION, 2020–2027(USD MILLION) 79
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 80
8.1 INTRODUCTION 81
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 81
8.2 HEALTH MANAGEMENT 81
8.2.1 HEALTH MANAGEMENT PLAYS A CRUCIAL TOOL
IN GUIDING PATIENTS IN SELF-CARE 81
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT,
BY REGION, 2020–2027(USD MILLION) 82
8.3 HOME HEALTH MANAGEMENT 82
8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT
THE MARKET GROWTH 82
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION) 82
8.4 SOCIAL & BEHAVIORAL MANAGEMENT 83
8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE THE MARKET GROWTH 83
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2020–2027(USD MILLION) 83
8.5 FINANCIAL HEALTH MANAGEMENT 84
8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS 84
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2020–2027(USD MILLION) 84
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 85
9.1 INTRODUCTION 86
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2020–2027 (USD MILLION) 86
9.2 CHRONIC DISEASES 86
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY REGION, 2020–2027 (USD MILLION) 87
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2020–2027 (USD MILLION) 87
9.2.1 CARDIOVASCULAR DISEASES (CVD) 87
9.2.1.1 CVD is the leading cause of death worldwide 87
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CVD, BY REGION,
2020–2027 (USD MILLION) 88
9.2.2 DIABETES 88
9.2.2.1 The high incidence of diabetes worldwide drives the growth of this segment 88
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES,
BY REGION, 2020–2027 (USD MILLION) 88
9.2.3 OBESITY 89
9.2.3.1 Rising prevalence of obesity to drive the growth of this segment 89
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2020–2027 (USD MILLION) 89
9.2.4 OTHER CHRONIC DISEASES 89
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2020–2027 (USD MILLION) 90
9.3 WOMEN’S HEALTH 90
9.3.1 INCREASING SELF AWARENESS FOR THE MANAGEMENT OF
DISEASES TO DRIVE THE MARKET GROWTH 90
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH,
BY REGION, 2020–2027 (USD MILLION) 90
9.4 FITNESS 91
9.4.1 GROWING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT THE MARKET GROWTH FOR FITNESS-RELATED APPS 91
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2020–2027 (USD MILLION) 91
9.5 OTHER THERAPEUTIC AREAS 92
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2020–2027 (USD MILLION) 92
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY 93
10.1 INTRODUCTION 94
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY,
2020–2027 (USD MILLION) 94
10.1.1 E-PRESCRIBING 94
10.1.1.1 E-prescribing is a cost-effective method of providing valuable information to clinicians to enhance decision-making 94
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING,
BY REGION, 2020–2027 (USD MILLION) 95
10.1.2 VIRTUAL CONSULTATION 95
10.1.2.1 Telehealth provides flexibility in treatment options due to remote monitoring 95
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR VIRTUAL CONSULTATION, BY REGION, 2020–2027 (USD MILLION) 96
10.1.3 PATIENT/CLIENT SCHEDULING 96
10.1.3.1 Patient/client scheduling enables physicians to streamline workflows and efficiently manage patient schedules 96
TABLE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2020–2027 (USD MILLION) 96
10.1.4 DOCUMENT MANAGEMENT 97
10.1.4.1 The effective management of patient documents is crucial for healthcare providers 97
TABLE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION) 97
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 98
11.1 INTRODUCTION 99
TABLE 35 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 99
11.2 PROVIDERS 99
11.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS 99
TABLE 36 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2020–2027 (USD MILLION) 100

11.3 PAYERS 100
11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE
PAYERS MINIMIZE ERRORS 100
TABLE 37 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION) 101
11.4 PATIENTS 101
11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS
TO MONITOR & IMPROVE HEALTH OUTCOMES 101
TABLE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS,
BY REGION, 2020–2027 (USD MILLION) 101
11.5 OTHER END USERS 102
TABLE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS,
BY REGION, 2020–2027 (USD MILLION) 102
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 103
12.1 INTRODUCTION 104
TABLE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2020–2027(USD MILLION) 104
12.2 NORTH AMERICA 105
FIGURE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 105
TABLE 41 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 42 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2020–2027 (USD MILLION) 106
TABLE 43 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2020–2027 (USD MILLION) 106
TABLE 44 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2020–2027 (USD MILLION) 107
TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 46 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 107
TABLE 47 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY FUNCTIONALITY, 2020–2027 (USD MILLION) 108
12.2.1 US 108
12.2.1.1 The US is the largest market in North America for patient engagement solutions in 2022 108
TABLE 48 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 109
TABLE 49 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2020–2027 (USD MILLION) 109
TABLE 50 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 110
TABLE 51 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 110
TABLE 52 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 110
12.2.2 CANADA 111
12.2.2.1 Growing need for cost containment to propel the
market growth in Canada 111
TABLE 53 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 111
TABLE 54 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 112
TABLE 55 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 112
TABLE 56 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112
TABLE 57 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 113
12.3 EUROPE 113
TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 113
TABLE 59 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 114
TABLE 60 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 114
TABLE 61 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 114
TABLE 62 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
TABLE 63 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 115
TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027(USD MILLION) 115
12.3.1 GERMANY 116
12.3.1.1 Germany is the largest market for patient engagement solutions in Europe in 2022 116
TABLE 65 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 116
TABLE 66 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 117
TABLE 67 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 117
TABLE 68 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 69 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 118
12.3.2 FRANCE 118
12.3.2.1 Digital health insurance startups in France to drive the market growth for patient engagement solutions 118
TABLE 70 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 119
TABLE 71 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 119
TABLE 72 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
TABLE 73 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 74 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 120
12.3.3 UK 120
12.3.3.1 Favorable government initiatives to promote healthcare to support market growth in the UK 120
TABLE 75 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 121
TABLE 76 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2020–2027 (USD MILLION) 121
TABLE 77 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 122
TABLE 78 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 122
TABLE 79 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 122
12.3.4 SPAIN 123
12.3.4.1 Data security concerns restrict the market growth in Spain 123
TABLE 80 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 123
TABLE 81 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 124
TABLE 82 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 124
TABLE 83 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 84 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 125
12.3.5 ITALY 125
12.3.5.1 The growing burden of chronic diseases in Italy drives the demand for patient engagement solutions 125
TABLE 85 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 125
TABLE 86 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 126
TABLE 87 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 126
TABLE 88 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 126
TABLE 89 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 127
12.3.6 REST OF EUROPE (ROE) 127
TABLE 90 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 128
TABLE 91 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 128
TABLE 92 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 128
TABLE 93 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 129
TABLE 94 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 129
12.4 ASIA PACIFIC 129
FIGURE 21 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 130
TABLE 95 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 96 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 131
TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION) 131
TABLE 98 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
TABLE 99 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 100 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 132
TABLE 101 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY FUNCTIONALITY, 2020–2027 (USD MILLION) 133
12.4.1 JAPAN 133
12.4.1.1 The rising geriatric population in Japan supports the market growth for patient engagement solutions 133
TABLE 102 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 134
TABLE 103 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 134
TABLE 104 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 134
TABLE 105 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 106 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 135
12.4.2 CHINA 135
12.4.2.1 Implementation of EMR solutions in healthcare by the Chinese government is expected to drive the demand for patient engagement solutions 135
TABLE 107 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 136
TABLE 108 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 136
TABLE 109 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
TABLE 110 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027 USD MILLION) 137
TABLE 111 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION) 137
12.4.3 INDIA 138
12.4.3.1 High burden of chronic diseases to support the market growth for patient engagement solutions 138
TABLE 112 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 138
TABLE 113 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 139
TABLE 114 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 139
TABLE 115 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 139
TABLE 116 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 140
12.4.4 REST OF ASIA PACIFIC (ROAPAC) 140
TABLE 117 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 141
TABLE 118 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION) 141
TABLE 119 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 141
TABLE 120 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020–2027(USD MILLION) 142
TABLE 121 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027(USD MILLION) 142
12.5 REST OF THE WORLD 142
TABLE 122 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY REGION, 2020–2027 (USD MILLION) 142
TABLE 123 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020–2027 (USD MILLION) 143
TABLE 124 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027(USD MILLION) 143
TABLE 125 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020–2027 (USD MILLION) 143
TABLE 126 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 144
TABLE 127 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 144
TABLE 128 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2020–2027 (USD MILLION) 144
12.5.1 LATIN AMERICA 145
12.5.1.1 Developments in healthcare infrastructure to support the market growth 145
TABLE 129 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2020–2027 (USD MILLION) 145
TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 146
TABLE 131 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 146
TABLE 132 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 133 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 147
12.5.2 MIDDLE EAST & AFRICA 147
12.5.2.1 Rising government support to drive the market growth for patient engagement solutions in the MEA 147
TABLE 134 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2020–2027 (USD MILLION) 147
TABLE 135 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2020–2027 (USD MILLION) 148
TABLE 136 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2020–2027(USD MILLION) 148
TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 138 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 149
13 COMPETITIVE LANDSCAPE 150
13.1 OVERVIEW 150
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 150
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET 151
13.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 152
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET 153
13.4 MARKET RANKING 153
FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021 153
13.5 COMPETITIVE BENCHMARKING 154
TABLE 139 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 154
TABLE 140 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST
OF KEY STARTUP/SMES 155
13.6 COMPETITIVE LEADERSHIP MAPPING 156
13.6.1 STARS 156
13.6.2 EMERGING LEADERS 156
13.6.3 PERVASIVE PLAYERS 156
13.6.4 PARTICIPANTS 156
FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021 157
13.7 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME 158
13.7.1 PROGRESSIVE COMPANIES 158
13.7.2 STARTING BLOCKS 158
13.7.3 RESPONSIVE COMPANIES 158
13.7.4 DYNAMIC COMPANIES 158
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET 159

13.8 COMPETITIVE SITUATIONS AND TRENDS 160
13.8.1 PRODUCT LAUNCHES 160
13.8.2 DEALS 161
14 COMPANY PROFILES 166
14.1 KEY PLAYERS 166
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 IBM 166
TABLE 141 IBM: BUSINESS OVERVIEW 166
FIGURE 26 IBM: COMPANY SNAPSHOT (2021) 167
14.1.2 MCKESSON CORPORATION 170
TABLE 142 MCKESSON CORPORATION: BUSINESS OVERVIEW 170
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021) 170
14.1.3 ALLSCRIPTS HEALTHCARE SOLUTIONS INC 174
TABLE 143 ALLSCRIPTS HEALTHCARE SOLUTIONS INC: BUSINESS OVERVIEW 174
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021) 175
14.1.4 ATHENAHEALTH 178
TABLE 144 ATHENAHEALTH: BUSINESS OVERVIEW 178
14.1.5 ORION HEALTH 181
TABLE 145 ORION HEALTH: BUSINESS OVERVIEW 181
14.1.6 CERNER CORPORATION 183
TABLE 146 CERNER: BUSINESS OVERVIEW 183
FIGURE 29 CERNER CORPORATION: COMPANY SNAPSHOT (2021) 184
14.1.7 GETWELLNETWORK, INC. 187
TABLE 147 GETWELL NETWORK INC: BUSINESS OVERVIEW 187
14.1.8 LINCOR SOLUTIONS 189
TABLE 148 LINCOR SOLUTIONS: BUSINESS OVERVIEW 189
14.1.9 COGNIZANT 191
TABLE 149 COGNIZANT: BUSINESS OVERVIEW 191
FIGURE 30 COGNIZANT: COMPANY SNAPSHOT (2020) 191
14.1.10 HARRIS HEALTHCARE 193
TABLE 150 HARRIS HEALTHCARE: BUSINESS OVERVIEW 193
14.2 OTHER KEY PLAYERS 194
14.2.1 GET REAL HEALTH 194
14.2.2 ONEVIEW HEALTHCARE 195
14.2.3 ADVANCEDMD 196
14.2.4 EPIC SYSTEMS CORPORATION 197
14.2.5 MEDITECH 198
14.2.6 KAREO 199
14.2.7 ECLINICAL WORKS 199
14.2.8 WELLSTACK 200
14.2.9 IQVIA 200
14.2.10 VIVIFY HEALTH 201
14.2.11 MEDHOST 201
14.2.12 VALIDIC 202
14.2.13 CUREMD HEALTHCARE 202
14.2.14 MEDISYSINC.COM 203
14.2.15 PATIENTPOINT, LLC 203
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 204
15.1 DISCUSSION GUIDE 204
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
15.3 AVAILABLE CUSTOMIZATIONS 210
15.4 RELATED REPORTS 210
15.5 AUTHOR DETAILS 211

ページTOPに戻る

Table of Contents

Summary

The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps.
However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

“Services segment is expected to grow at the highest rate during the forecast period”
On basis of components, the patient engagement solutions market is segmented into software, hardware, and services. The software segment accounted for the largest share of the global patient engagement solutions market in 2021. The software market is further segmented into standalone solutions and integrated solutions. In 2021, the integrated solutions segment has accounted for the larger share of this market & is also expected to grow at the highest CAGR during the forecast period.
However, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of the services segment can be attributed to the services being indispensable for the application of deployed solutions.

“The On-premise solutions segment is estimated to account for the largest share of the Patient Engagement Solutions market in 2022”
Based on delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. In 2021, the on-premise solutions segment accounted for the largest share of the global patient engagement solutions market. However, the cloud-based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability are the features offered by cloud-based solutions that are supporting its growth in the patient engagement solutions market.

“Health management segment in the applications accounted for the largest share of the global patient engagement solutions market”

Based on application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. The health management applications segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increased awareness among patients about the health conditions cause by severe diseases and their willingness to actively participate in maintaining their own health.

“Chronic diseases among the therapeutic areas accounted for the largest share of the global patient engagement solutions market”

Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women’s health, fitness, and other therapeutic areas. The chronic diseases segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increase in various chronic diseases and the need to manage these conditions with reduced healthcare costs.

“The E- Prescribing functionality is expected to grow with the highest CAGR during the forecast period”

Based on functionality, the patient engagement solutions market is segmented into E-prescribing, virtual consultation, patient/client scheduling, and document management. The patient/client scheduling segment accounted for the largest share of the global patient engagement solutions market in 2021. The large share of this segment can be attributed to the increasing productivity and efficient care through proper scheduling of appointments. The E- Prescribing segment is expected to grow with the highest CAGR during the forecast period

“Providers' segment accounted for the largest share of the global patient engagement solutions market”

Based on end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users. The providers' segment accounted for the largest share of the global patient engagement solutions market in 2021. High adoption of patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes are factors that are supporting the growth of this segment. Patient engagement solutions also help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients to self-manage their care.

“North America to dominate the patient engagement solutions market in 2022”
North America accounted for the largest share of the global patient engagement solutions market in 2021. Changing government initiatives and regulations in the region , the need to cut down on healthcare costs, the rising prevalence of chronic diseases, and the key market players operating in the region are the key factors driving the growth of the patient engagement solutions market in North America.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the increasing adoption of HCIT solutions and the growing prevalence of chronic diseases in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Region: North America (46%), Europe (26%), Asia Pacific (18%), and RoW (10%)

Prominent players in this market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage
• The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total remote patient monitoring market
• The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Patient Engagement Solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（クラウド）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（クラウド）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?